Phenotypic characterization of spatial cognition and social behavior in mice with ‘knockout’ of the schizophrenia risk gene neuregulin 1

Neuregulin-1 (NRG1) has been identified as a candidate susceptibility gene for schizophrenia. In the present study the functional role of the NRG1 gene, as it relates to cognitive and social processes known to be disrupted in schizophrenia, was assessed in mice with heterozygous deletion of transmembrane (TM)-domain NRG1 in comparison with wildtypes (WT). Social affiliative behavior was assessed using the sociability and preference for social novelty paradigm, in terms of time spent in: (i) a chamber containing an unfamiliar conspecific vs. an empty chamber (sociability), or (ii) a chamber containing an unfamiliar conspecific vs. a chamber containing a familiar conspecific (preference for social novelty). Social dominance and aggressive behavior were examined in the resident-intruder paradigm. Spatial learning and memory were assessed using the Barnes maze paradigm, while spatial working memory was measured using the continuous variant of the spontaneous alternation task. Barnes maze data revealed intact spatial learning in NRG1 mutants, with elevated baseline latency to enter the escape hole in male NRG1 mutants reflecting an increase in activity level. Similarly, although a greater number of overall arm entries were found, spontaneous alternation was unaffected in NRG1 mice. Social affiliation data revealed NRG1 mutants to evidence a specific loss of WT preference for spending time with an unfamiliar as opposed to a familiar conspecific. This suggests that NRG1 mutants show a selective impairment in response to social novelty. While spatial learning and working memory processes appear intact, heterozygous deletion of TM-domain NRG1 was associated with disruption to social novelty behavior. These data inform at a novel phenotypic level on the functional role of this gene in the context of its association with risk for schizophrenia.

[1]  J. Buxbaum,et al.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.

[2]  D. Clair,et al.  Confirmation and refinement of an ‘at-risk’ haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus , 2004, Molecular Psychiatry.

[3]  G. Arendash,et al.  Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease , 1999, Journal of Neuroscience Methods.

[4]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[5]  R. Gerlai,et al.  Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks , 2000, Behavioural Brain Research.

[6]  G. Fischbach,et al.  Differential expression of ARIA isoforms in the rat brain , 1995, Neuron.

[7]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[8]  N. Andreasen Schizophrenia: the fundamental questions , 2000, Brain Research Reviews.

[9]  Paul J. Harrison,et al.  Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain , 2004, Neuroscience.

[10]  J. Gogos,et al.  Modeling Madness in Mice: One Piece at a Time , 2006, Neuron.

[11]  J. Loeb,et al.  Neuregulins: Versatile growth and differentiation factors in nervous system development and human disease , 2006, Brain Research Reviews.

[12]  T. Holy,et al.  Loss of sex discrimination and male-male aggression in mice deficient for TRP2. , 2002, Nature Reviews Genetics.

[13]  M. Munafo,et al.  Association of the NRG1 gene and schizophrenia: a meta-analysis , 2006, Molecular Psychiatry.

[14]  K. Seroogy,et al.  Supranigral injection of neuregulin1-β induces striatal dopamine overflow , 2004, Brain Research.

[15]  C. Salum,et al.  The effect of amphetamine on Kamin blocking and overshadowing , 2003, Behavioural pharmacology.

[16]  Maria Karayiorgou,et al.  Schizophrenia genetics: uncovering positional candidate genes , 2006, European Journal of Human Genetics.

[17]  H. Eichenbaum,et al.  The perirhinal–entorhinal cortex, but not the hippocampus, is critical for expression of individual recognition in the context of the Coolidge effect , 2003, Neuroscience.

[18]  J. Waddington,et al.  Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour , 2007, Neuroscience & Biobehavioral Reviews.

[19]  M. A. De Luca,et al.  Differential Expression of Motivational Stimulus Properties by Dopamine in Nucleus Accumbens Shell versus Core and Prefrontal Cortex , 2002, The Journal of Neuroscience.

[20]  Zhen Yan,et al.  Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.

[21]  G. Thaker,et al.  Advances in schizophrenia , 2001, Nature Medicine.

[22]  M. Golub,et al.  Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse , 2004, Behavioural Brain Research.

[23]  Marc G Caron,et al.  Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.

[24]  J. Waddington,et al.  The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease , 1999, Biological Psychiatry.

[25]  S. Kapur,et al.  From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis , 2005, Schizophrenia Research.

[26]  D. Hoffman,et al.  Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses , 2005, The Journal of Neuroscience.

[27]  J. Piven,et al.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.

[28]  C. Vorhees,et al.  Effects of prenatal cocaine on Morris and Barnes maze tests of spatial learning and memory in the offspring of C57BL/6J mice. , 2000, Neurotoxicology and teratology.

[29]  R. Freedman,et al.  Genetics of Chromosome 15q13-q14 in Schizophrenia , 2006, Biological Psychiatry.

[30]  D. Grandy,et al.  Ethological resolution of behavioral topography and D2‐like vs. D1‐like agonist responses in congenic D4 dopamine receptor “knockouts”: Identification of D4:D1‐like interactions , 2006, Synapse.

[31]  J. Addington,et al.  The course of cognitive functioning in first episode psychosis: Changes over time and impact on outcome , 2005, Schizophrenia Research.

[32]  Lee M. Silver,et al.  Social approach–avoidance behavior of inbred mouse strains towards DBA/2 mice , 2004, Brain Research.

[33]  D. Sibley,et al.  Ethological resolution of behavioural topography and D1‐like versus D2‐like agonist responses in congenic D5 dopamine receptor mutants: Identification of D5:D2‐like interactions , 2005, Synapse.

[34]  R. Siegel,et al.  Neuregulin induces GABAA receptor β2 subunit expression in cultured rat cerebellar granule neurons by activating multiple signaling pathways , 2004, Journal of neurochemistry.

[35]  J. Coyle,et al.  NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. , 2004, International review of neurobiology.

[36]  B. Galef,et al.  Acute anosmia in the rat: a behavioral test of a peripherally-induced olfactory deficit. , 1971, Physiology & behavior.

[37]  Johannes Schwarz,et al.  Psychosis pathways converge via D2High dopamine receptors , 2006, Synapse.

[38]  A. Cools,et al.  Distinct kinds of novelty processing differentially increase extracellular dopamine in different brain regions , 2006, The European journal of neuroscience.

[39]  Karin E. Borgmann-Winter,et al.  Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.

[40]  E. Kandel,et al.  Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the θ frequency , 1995, Cell.

[41]  J. Waddington,et al.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology–molecular biology interface , 2005, Psychopharmacology.

[42]  Robert Freedman,et al.  Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia , 2006 .

[43]  D. Weinberger,et al.  Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models , 2006, Biological Psychiatry.

[44]  G. Fischbach,et al.  An acute effect of neuregulin 1 beta to suppress alpha 7-containing nicotinic acetylcholine receptors in hippocampal interneurons. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  Douglas L Falls,et al.  Neuregulins: functions, forms, and signaling strategies. , 2003, Experimental cell research.

[46]  A. Arnold,et al.  Tissue-specific expression and regulation of sexually dimorphic genes in mice. , 2006, Genome research.

[47]  A. Holmes,et al.  Behavioral profiles of inbred strains on novel olfactory, spatial and emotional tests for reference memory in mice , 2002, Genes, brain, and behavior.

[48]  Tobias M. Fischer,et al.  Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain , 2004, Nature Neuroscience.

[49]  J. Lieberman,et al.  Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function , 2004, Behavioural Brain Research.

[50]  G. Kreutzberg,et al.  Neuregulin-1 isoforms are differentially expressed in the intact and regenerating adult rat nervous system , 2007, Journal of Molecular Neuroscience.

[51]  Kari Stefansson,et al.  Multiple novel transcription initiation sites for NRG1. , 2004, Gene.

[52]  Paul J. Harrison,et al.  Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology , 2006, Biological Psychiatry.

[53]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[54]  A. Fasolo,et al.  Differential expression of neuregulins and their receptors in the olfactory bulb layers of the developing mouse , 2006, Brain Research.

[55]  M. Millan N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives , 2005, Psychopharmacology.

[56]  R. Freedman,et al.  Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. , 2006, Archives of general psychiatry.

[57]  G. Corfas,et al.  Neuregulin1 downregulates postsynaptic GABAa receptors at the hippocampal inhibitory synapse , 2004, Hippocampus.

[58]  Douglas W. Barrett,et al.  Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition , 2005, Neuroreport.

[59]  A. Malla,et al.  First-episode psychosis: psychopathology, quality of life, and functional outcome. , 2005, Schizophrenia bulletin.

[60]  Paul J. Harrison,et al.  Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Buonanno,et al.  Neuregulin‐2 is developmentally regulated and targeted to dendrites of central neurons , 2004, The Journal of comparative neurology.

[62]  G. Fischbach,et al.  An Acute Effect of Neuregulin 1β to Suppress α7-Containing Nicotinic Acetylcholine Receptors in Hippocampal Interneurons , 2006, The Journal of Neuroscience.

[63]  N. Tatarenko [Pathophysiology of schizophrenia]. , 1954, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova.

[64]  Philip D. Harvey,et al.  Cognition in schizophrenia: impairments, determinants, and functional importance. , 2005, The Psychiatric clinics of North America.

[65]  G. Kirov,et al.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[66]  K. Seroogy,et al.  Supranigral injection of neuregulin1-beta induces striatal dopamine overflow. , 2004, Brain research.

[67]  J. Waddington,et al.  Sexually dimorphic changes in the exploratory and habituation profiles of heterozygous neuregulin-1 knockout mice , 2006, Neuroreport.

[68]  M J Owen,et al.  Schizophrenia: genes at last? , 2005, Trends in genetics : TIG.

[69]  A. Blokland,et al.  Assessment of spatial learning abilities of mice in a new circular maze , 2003, Physiology & Behavior.

[70]  P. M. Wall,et al.  Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory , 2002, Psychopharmacology.

[71]  L. Almasy,et al.  A Novel Missense Mutation in the Transmembrane Domain of Neuregulin 1 is Associated with Schizophrenia , 2006, Biological Psychiatry.

[72]  Edward S. Brodkin,et al.  A Mouse Model System for Genetic Analysis of Sociability: C57BL/6J Versus BALB/cJ Inbred Mouse Strains , 2006, Biological Psychiatry.

[73]  Heather C Whalley,et al.  A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms , 2006, Nature Neuroscience.

[74]  R. Schreiber,et al.  AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors , 2004, Psychopharmacology.